logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Cost effectiveness of medical versus surgical treatment in patients with severe or refractory gastroesophageal reflux disease in the Netherlands.

    Article - En anglais

    Background 

    For a significant number of patients with severe or refractory gastroesophageal reflux disease, maintenance treatment with omeprazole and reflux surgery (Nissen fundoplication) are alternative treatment options.

    In this study maintenance treatment with omeprazole is compared with open and laparoscopic Nissen fundoplication from a health-economic perspective.

    Methods 

    Metaanalysis of published articles to assess effectiveness and simple decision-analytic techniques to combine costs and effects are used.

    Findings and assumptions are submitted to sensitivity analysis.

    Results 

    It is estimated that it costs approximately 1880 Dutch guilders to initially heal a patient with severe or refractory esophagitis with 40 mg omeprazole daily.

    When medical maintenance therapy was compared with surgery, it appeared that medical maintenance therapy with omeprazole (20-40 mg daily) for a prolonged period of time (more than 4 years) is less cost effective than a Nissen procedure.

    It is estimated that a laparoscopic Nissen will shift this so-called break-even point towards 1.4 years, mainly due to a shorter hospital stay.

    Conclusions 

    Although caution is required in drawing conclusions, it appears that replacing treatment with (laparoscopic) Nissen fundoplications in these patients might lead to substantial savings.

    Mots-clés Pascal : Reflux gastrooesophagien, Réfractaire, Pays Bas, Europe, Oméprazole, Antisécrétoire, Inhibiteur enzyme, H+/K+-exchanging ATPase, Hydrolases, Enzyme, Intervention Nissen, Chimiothérapie, Etude comparative, Coût, Traitement, Homme, Economie santé, Appareil digestif pathologie, Oesophage pathologie, Chirurgie

    Mots-clés Pascal anglais : Gastroesophageal reflux, Refractory, Netherlands, Europe, Antisecretory agent, Enzyme inhibitor, H+/K+-exchanging ATPase, Hydrolases, Enzyme, Nissen operation, Chemotherapy, Comparative study, Costs, Treatment, Human, Health economy, Digestive diseases, Esophageal disease, Surgery

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 96-0080356

    Code Inist : 002B13A03. Création : 199608.